Bioengineering professors receive $4.8M to develop gene therapy for ALS
February 1, 2022
The NIH National Institute of Neurological Disorders and Stroke (NINDS) awarded University of Illinois bioengineering professors Thomas Gaj (BSD) and Pablo Perez-Pinera (ACPP) a five-year, approximately $4.8 million translational research grant to develop an optimized gene therapy for amyotrophic lateral sclerosis (ALS), a severely debilitating and fatal neurological disorder.
February 1, 2022
